Optimization of Time-of-Flight Mass Cytometry (CyTOF) Analysis for

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Surgical trauma triggers a massive inflammatory response. Over time, both the innate and adaptive branches of the immune system are affected by surgical trauma. The purpose of this study is to use a single cell flow cytometry approach to characterize the cellular and molecular mechanisms involved in the inflammatory response to surgical trauma.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01578798` - Detection of Immune Changes as a Result of Surgical Trauma in Human Subject	N/A
	Completed	`NCT06405659` - Immediate Fever During Anaesthesia Recovery After Surgical Procedure With Scoliosis

NCT number	NCT01882569
Study type	Observational
Source	Stanford University
Contact
Status	Completed
Phase	N/A
Start date	May 2012
Completion date	September 2014

Optimization of Time-of-Flight Mass Cytometry (CyTOF) Analysis for Evaluation of Immune Changes Following Surgery

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms